News

Psychedelics caucus launched to research benefits of mushrooms and LSD

By Abigail Adcox
Published November 17, 2022 10:04pm ET
Add Washington Examiner on Google
Psychedelics caucus launched to research benefits of mushrooms and LSD
In this May 24, 2019, file photo a vendor bags psilocybin mushrooms at a pop-up cannabis market in Los Angeles.

A pair of lawmakers announced Thursday they are forming a bipartisan congressional caucus devoted to psychedelic therapy.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Congress Drugs Health research